Member Spotlight: DNB and Entering the U.S. Life Science Market

What does it actually take for a Nordic life science company to succeed in the United States? In this inaugural FACC-NY Member Spotlight, Andreas Dirnagl, Head of Healthcare Strategy at DNB, draws on more than three decades of experience in healthcare finance to share practical lessons for companies looking to enter the world’s largest healthcare market. The conversation explores why success depends on far more than innovative science, highlighting the importance of understanding the scale of the U.S. market, adapting to its commercial culture, navigating its complex reimbursement system, and building strong local partnerships. Dirnagl also discusses the growing role of AI in healthcare, what American investors look for, and why commercial strategy and execution are just as critical as the technology itself. Concluding with ten actionable takeaways, this spotlight provides founders, executives, and innovators with a practical roadmap for expanding into the U.S. and building sustainable, long-term success.

Read the full Member Spotlight here: Member-Spotlight-1.pdf